Flow-controlled ventilation in moderate acute respiratory distress syndrome due to COVID-19: an open-label repeated-measures controlled trial

被引：0
|
作者：
Eleni D. Van Dessel
Gregory R. De Meyer
Stuart G. Morrison
Philippe G. Jorens
Tom Schepens
机构：
[1] Antwerp University Hospital/University of Antwerp,Department of Critical Care Medicine
[2] Antwerp University Hospital/University of Antwerp,Department of Anesthesiology
来源：
Intensive Care Medicine Experimental | / 10卷
关键词：
COVID-19; ARDS; Flow-controlled ventilation; Mechanical ventilation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Flow-controlled ventilation in moderate acute respiratory distress syndrome due to COVID-19: an open-label repeated-measures controlled trial
    Van Dessel, Eleni D.
    De Meyer, Gregory R.
    Morrison, Stuart G.
    Jorens, Philippe G.
    Schepens, Tom
    INTENSIVE CARE MEDICINE EXPERIMENTAL, 2022, 10 (01)
  • [2] Flow controlled ventilation in Acute Respiratory Distress Syndrome associated with COVID-19: A structured summary of a study protocol for a randomised controlled trial
    Roehrig, Stefan
    Hssain, Ali Ait
    Shallik, Nabil Al Hamid
    Elsaid, Ingi Mohamed A.
    Mustafa, Salma Faisal
    Smain, Osama A. M.
    Molokhia, Ashraf Abdulla
    Lance, Marcus D.
    TRIALS, 2020, 21 (01)
  • [3] Flow controlled ventilation in Acute Respiratory Distress Syndrome associated with COVID-19: A structured summary of a study protocol for a randomised controlled trial
    Stefan Roehrig
    Ali Ait Hssain
    Nabil Al Hamid Shallik
    Ingi Mohamed A. Elsaid
    Salma Faisal Mustafa
    Osama A. M. Smain
    Ashraf Abdulla Molokhia
    Marcus D. Lance
    Trials, 21
  • [4] NONINVASIVE VENTILATION FOR MODERATE TO SEVERE ACUTE RESPIRATORY DISTRESS SYNDROME DUE TO COVID-19
    Botsch, Alexander A.
    Oravec, Michael J.
    Rapier, Brandon T.
    Goff, Laine M.
    Desmett, Ashley L.
    AMERICAN JOURNAL OF CRITICAL CARE, 2024, 33 (04) : 260 - 269
  • [5] Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial
    Dongsheng Wang
    Binqing Fu
    Zhen Peng
    Dongliang Yang
    Mingfeng Han
    Min Li
    Yun Yang
    Tianjun Yang
    Liangye Sun
    Wei Li
    Wei Shi
    Xin Yao
    Yan Ma
    Fei Xu
    Xiaojing Wang
    Jun Chen
    Daqing Xia
    Yubei Sun
    Lin Dong
    Jumei Wang
    Xiaoyu Zhu
    Min Zhang
    Yonggang Zhou
    Aijun Pan
    Xiaowen Hu
    Xiaodong Mei
    Haiming Wei
    Xiaoling Xu
    Frontiers of Medicine, 2021, 15 : 486 - 494
  • [6] Tocilizumab in patients with moderate or severe COVID-19:a randomized, controlled, open-label, multicenter trial
    Dongsheng Wang
    Binqing Fu
    Zhen Peng
    Dongliang Yang
    Mingfeng Han
    Min Li
    Yun Yang
    Tianjun Yang
    Liangye Sun
    Wei Li
    Wei Shi
    Xin Yao
    Yan Ma
    Fei Xu
    Xiaojing Wang
    Jun Chen
    Daqing Xia
    Yubei Sun
    Lin Dong
    Jumei Wang
    Xiaoyu Zhu
    Min Zhang
    Yonggang Zhou
    Aijun Pan
    Xiaowen Hu
    Xiaodong Mei
    Haiming Wei
    Xiaoling Xu
    Frontiers of Medicine, 2021, 15 (03) : 486 - 494
  • [7] Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial
    Wang, Dongsheng
    Fu, Binqing
    Peng, Zhen
    Yang, Dongliang
    Han, Mingfeng
    Li, Min
    Yang, Yun
    Yang, Tianjun
    Sun, Liangye
    Li, Wei
    Shi, Wei
    Yao, Xin
    Ma, Yan
    Xu, Fei
    Wang, Xiaojing
    Chen, Jun
    Xia, Daqing
    Sun, Yubei
    Dong, Lin
    Wang, Jumei
    Zhu, Xiaoyu
    Zhang, Min
    Zhou, Yonggang
    Pan, Aijun
    Hu, Xiaowen
    Mei, Xiaodong
    Wei, Haiming
    Xu, Xiaoling
    FRONTIERS OF MEDICINE, 2021, 15 (03) : 486 - 494
  • [8] Efficacy of Favipiravir in the Treatment of Moderate COVID-19 Patients: A Randomized, Open-label, Controlled Clinical Trial
    Tehrani, Shabnam
    Yadegarynia, Davood
    Bagherzade, Afshin
    Gachkar, Latif
    Keyvanfar, Amirreza
    MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2022, 11
  • [9] Flow-Controlled Ventilation Attenuates Lung Injury in a Porcine Model of Acute Respiratory Distress Syndrome: A Preclinical Randomized Controlled Study
    Schmidt, Johannes
    Wenzel, Christin
    Spassov, Sashko
    Borgmann, Silke
    Lin, Ziwei
    Wollborn, Jakob
    Weber, Jonas
    Haberstroh, Joerg
    Meckel, Stephan
    Eiden, Sebastian
    Wirth, Steffen
    Schumann, Stefan
    CRITICAL CARE MEDICINE, 2020, 48 (03) : E241 - E248
  • [10] Ribavirin aerosol in hospitalized adults with respiratory distress and COVID-19: An open-label trial
    Poulakou, Garyfallia
    Barakat, Maxime
    Israel, Robert J.
    Bacci, Marcelo R.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (01): : 165 - 174
12345